What does Genaxis do?
GENAXIS specializes in providing advanced genomic solutions and services to enhance research and development in life sciences. The company focuses on cutting-edge technologies for genetic analysis, enabling innovations in diagnostics and personalized medicine. By leveraging its expertise, GENAXIS aims to support researchers and healthcare professionals in making informed decisions based on genetic data.
Juridical situation
Company number
Founding date
EUID number
Type of enterprise
Location
Juridical form
- Signals
-
ProfitableProfitable € 7.51M
The company reported a positive net result in the latest financial year.
Strong equityStrong equity € 15.05MStrong equity provides a buffer against setbacks.
Low riskLow risk 85.0%Good solvency (> 30%) points to long-term financial stability.
Good liquidityGood liquidity 1.72A healthy current ratio (≥ 1.5): enough current assets to cover short-term debt.
Positive cashflowPositive cashflow € 8.76MPositive operating cash flow in the latest financial year.
Positive EBITDAPositive EBITDA € 11.95MPositive EBITDA: operating activities are profitable.
Healthy social debtHealthy social debt 21.9%Social debts stay manageable relative to personnel costs.
|
|
2025
|
2024
|
2023
|
2022
|
|---|---|---|---|---|
|
€
12.02M
|
€
4.13M
|
€
885K
|
€
1.32M
|
|
|
€
11.95M
|
€
4.06M
|
€
866K
|
€
1.24M
|
|
|
€
7.51M
|
€
2.63M
|
€
446K
|
€
845K
|
|
|
€
15.05M
|
€
8.32M
|
€
3.51M
|
€
3.11M
|
|
|
84.95%
|
91.37%
|
87.29%
|
78.28%
|
|
|
€
2.27M
|
€
379K
|
€
80K
|
€
425K
|
|
|
€
3.65M
|
€
2.40M
|
€
730K
|
€
2.24M
|
|
|
0.80
|
0.80
|
|
1.00
|
Publications 28
All publications- Statuten (Vertaling, Cordinatie, Overige Wijzigingen, ) - Diversen - Doel - Ontslagen - Benoemingen 17/11/2023
- Maatschappelijke Zetel 14/12/2022
- Ontslagen - Benoemingen 09/12/2016
- Me. - Jaarrekening 29.02.2016, Ggk 31.08.2016, Ngl 21.10.2016 16660-0514-017 26/10/2016
- Me. - Jaarrekening 28.02.2015, Ggk 31.08.2015, Ngl 30.10.2015 15659-0366-017 03/11/2015
Frequently asked questions
Answers to the most common questions about Genaxis, based on official government data and the filed annual accounts.
What is the VAT number of Genaxis?
The VAT number of Genaxis is BE0463.935.657.
How many employees work at Genaxis?
In 2025, Genaxis employed 0.80 full-time equivalents (FTE).
When was Genaxis established?
Genaxis was founded in 04-08-1998.
What is the official address of Genaxis?
The official address of Genaxis is Lindenstraat 15 Sint-Martens-Latem 9831.
What is the legal form of Genaxis?
The juridical form of Genaxis is Public limited company (NV/SA).
What is the legal situation of Genaxis?
The legal situation of Genaxis is Normal situation.
What is the annual revenue of Genaxis?
The annual revenue of Genaxis is €0.
What does Genaxis do?
GENAXIS specializes in providing advanced genomic solutions and services to enhance research and development in life sciences. The company focuses on cutting-edge technologies for genetic analysis, enabling innovations in diagnostics and personalized medicine. By leveraging its expertise, GENAXIS aims to support researchers and healthcare professionals in making informed decisions based on genetic data.
Where can I find Genaxis?
Genaxis is located at Lindenstraat 15 Sint-Martens-Latem 9831 in Sint-Martens-Latem (9831).
Is Genaxis a reliable company?
Genaxis is a registered Rechtspersoon with company number 0463.935.657 and can be verified through the official CBE database.
What is the credit limit of Genaxis?
The estimated credit limit of Genaxis is €10,000,000.
Is Genaxis still active?
Genaxis currently has the status "Normal situation" and is actief.